Microbix Biosystems Inc. (MBX) - Total Liabilities

Latest as of March 2026: CA$10.22 Million CAD ≈ $7.40 Million USD

Based on the latest financial reports, Microbix Biosystems Inc. (MBX) has total liabilities worth CA$10.22 Million CAD (≈ $7.40 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Microbix Biosystems Inc. - Total Liabilities Trend (1997–2025)

This chart illustrates how Microbix Biosystems Inc.'s total liabilities have evolved over time, based on quarterly financial data. See MBX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Microbix Biosystems Inc. Competitors by Total Liabilities

The table below lists competitors of Microbix Biosystems Inc. ranked by their total liabilities.

Company	Country	Total Liabilities
Arch Biopartners Inc V:ARCH	Canada	CA$3.62 Million
Trisula International Tbk JK:TRIS	Indonesia	Rp534.62 Billion
Lotus Eye Hospital and Institute Limited NSE:LOTUSEYE	India	Rs108.97 Million
Ram Technology Co. Ltd KQ:171010	Korea	₩68.89 Billion
Visi Media Asia Tbk JK:VIVA	Indonesia	Rp6.02 Trillion
D P Wires Limited NSE:DPWIRES	India	Rs-2.48 Billion
Agroton Public Ltd. WAR:AGT	Poland	zł2.76 Million
Partnera Oyj HE:PARTNE1	Finland	€26.74 Million

Liability Composition Analysis (1997–2025)

This chart breaks down Microbix Biosystems Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MBX stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.41	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.29	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Microbix Biosystems Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Microbix Biosystems Inc. (1997–2025)

The table below shows the annual total liabilities of Microbix Biosystems Inc. from 1997 to 2025.

Year	Total Liabilities	Change
2025-09-30	CA$9.62 Million ≈ $6.96 Million	-1.81%
2024-09-30	CA$9.80 Million ≈ $7.09 Million	-11.15%
2023-09-30	CA$11.03 Million ≈ $7.98 Million	+34.39%
2022-09-30	CA$8.21 Million ≈ $5.94 Million	-20.11%
2021-09-30	CA$10.27 Million ≈ $7.43 Million	+14.42%
2020-09-30	CA$8.98 Million ≈ $6.49 Million	-1.25%
2019-09-30	CA$9.09 Million ≈ $6.58 Million	+1.51%
2018-09-30	CA$8.96 Million ≈ $6.48 Million	-20.48%
2017-09-30	CA$11.26 Million ≈ $8.15 Million	+13.13%
2016-09-30	CA$9.96 Million ≈ $7.20 Million	+0.87%
2015-09-30	CA$9.87 Million ≈ $7.14 Million	+21.00%
2014-09-30	CA$8.16 Million ≈ $5.90 Million	+16.62%
2013-09-30	CA$6.99 Million ≈ $5.06 Million	-25.47%
2012-09-30	CA$9.39 Million ≈ $6.79 Million	+8.33%
2011-09-30	CA$8.66 Million ≈ $6.27 Million	-0.01%
2010-09-30	CA$8.66 Million ≈ $6.27 Million	+12.87%
2009-09-30	CA$7.68 Million ≈ $5.55 Million	+9.93%
2008-09-30	CA$6.98 Million ≈ $5.05 Million	+98.42%
2007-09-30	CA$3.52 Million ≈ $2.55 Million	+41.96%
2006-09-30	CA$2.48 Million ≈ $1.79 Million	+109.77%
2005-09-30	CA$1.18 Million ≈ $854.85K	+8.30%
2004-09-30	CA$1.09 Million ≈ $789.31K	+10.18%
2003-09-30	CA$990.31K ≈ $716.37K	+64.25%
2002-09-30	CA$602.93K ≈ $436.15K	-33.67%
2001-09-30	CA$908.94K ≈ $657.51K	-20.48%
2000-09-30	CA$1.14 Million ≈ $826.84K	+14.30%
1999-09-30	CA$1.00 Million ≈ $723.38K	-50.00%
1998-09-30	CA$2.00 Million ≈ $1.45 Million	+81.82%
1997-09-30	CA$1.10 Million ≈ $795.72K	--

About Microbix Biosystems Inc.

TO:MBX Canada Biotechnology

Market Cap

$29.84 Million

CA$41.25 Million CAD

Market Cap Rank

#23840 Global

#896 in Canada

Share Price

CA$0.30

Change (1 day)

-3.23%

52-Week Range

CA$0.21 - CA$0.31

All Time High

CA$0.84